Author

Magdalena Adde

Observed names: M A Adde, M Adde

Observed institutions: National Institutes of Health, Uppsala University Hospital

OpenAlex ID: A5000537332

Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.

1996 · I Magrath, M Adde, et al. · Journal of Clinical Oncology · 482

Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy

2007 · Heidi Nyman, Magdalena Adde, et al. · Blood · 277

Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine.

1996 · M Weintraub, M A Adde, et al. · Journal of Clinical Oncology · 65

Increased level of stromal cell-derived factor-1 mRNA in peripheral blood mononuclear cells from children with AIDS-related lymphoma.

2001 · S Sei, D P O'Neill, et al. · PubMed · 42

Outcome for Young High-Risk Aggressive B-Cell Lymphoma Patients Treated with CHOEP-14 and Rituximab (R-CHOEP-14)

2006 · Magdalena Adde, Gunilla Enblad, et al. · Medical Oncology · 16

Does Rituximab Influence the Prognostic Effect of Germinal Centre Phenotype in Diffuse Large B-Cell Lymphoma?.

2006 · Heidi Nyman, Marja-Liisa Karjalainen-Lindsberg, et al. · Blood · 1

Aggressive B-cell Lymphomas : Studies of Treatment, FDG-PET Evaluation and Prognostic Factors

2009 · Magdalena Adde · KTH Publication Database DiVA (KTH Royal Institute of Technology)

Little usefullness of mid-treatment FDG-PET and biopsy for treatment intensification in patients with aggressive lymphoma

2009 · Magdalena Adde, Jens Sörensen, et al.

Superior outcome in transformed follicular lymphoma compared to de novo aggressive B-cell lymphoma treated with high-dose therapy and autologous stem-cell support

2009 · Magdalena Adde, Anna Laurell, et al.

Works count: 9

Citation count: 883

H-index: 5

I10-index: 5